NCT03702673 is a Phase 1 clinical trial of K-877 CR Tablet A in Healthy, sponsored by Kowa Research Institute, Inc..

Who is sponsoring NCT03702673?

NCT03702673 is sponsored by Kowa Research Institute, Inc..

What drugs are being tested in NCT03702673?

Interventions in NCT03702673: K-877 CR Tablet A, K-877 CR Tablet B, K-877 CR Tablet E, K-877 IR Tablet.

Is NCT03702673 still recruiting?

NCT03702673 is currently completed. Last updated 19 December 2018.

Last reviewed 2018-12-19 · How we verify

NCT03702673

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.

Completed Phase 1 Last updated 19 December 2018

What this trial tests

Phase 1 trial testing K-877 CR Tablet A in Healthy in 12 participants. Completed in 20 November 2018.

Timeline

5 October 2018

Primary endpoint
20 November 2018

20 November 2018

Quick facts

Lead sponsor	Kowa Research Institute, Inc.
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	12
Start date	5 October 2018
Primary completion	20 November 2018
Estimated completion	20 November 2018
Sites	1 location across United States

Drugs / interventions tested

K-877 CR Tablet A — full drug profile →
K-877 CR Tablet B — full drug profile →
K-877 CR Tablet E — full drug profile →
K-877 IR Tablet — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Kowa Research Institute, Inc. — full company profile →

Who can join

Adults 18 to 45, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study to compare the pharmacokinetics of 3 types of K-877 controlled release tablets with a current normal K-877 tablet in healthy adult subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Kowa Research Institute, Inc. trials

Trials by the same sponsor.

NCT06525311 — A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis · Phase 1 · completed
NCT05826353 — A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexi · Phase 3 · completed
NCT05795699 — A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothel · Phase 3 · completed
NCT05722262 — Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration · Phase 1 · completed
NCT05327127 — Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis · Phase 2 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03702673 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kowa Research Institute, Inc.
Last refreshed: 19 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03702673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing